Director Guerrero Ramiro bought 37,595 MAIA Biotechnology shares at $1.32 per share on 2026-09-10, increasing his resulting holding to 773,296 shares. The purchase represents about 4.9% of that holding and is classified as an open-market purchase, giving investors a precise view of the transaction’s size within his reported position.

Key Highlights

  • Transaction code P classifies Guerrero Ramiro’s purchase as an open-market transaction.
  • Guerrero Ramiro’s reported holding after the purchase was 773,296 shares.
  • The transaction represented about 4.9% of his resulting shareholding.

MAIA Biotechnology, Inc. (AMEX: MAIA) director Guerrero Ramiro bought 37,595 shares at $1.32 per share on 10 September 2026.

Purchase Classified as Open-Market Transaction

The transaction carries code P, which identifies an open-market purchase in the Form 4 transaction classification. The reported post-transaction position was 773,296 shares. The purchase price applies to each share acquired. The transaction record ties the $1.32 price specifically to the 37,595 shares bought by Ramiro. The transaction represented about 4.9% of Ramiro’s resulting shareholding.